Company Overview - DeFi Development Corp. (Nasdaq: DFDV) has a treasury policy that allocates its principal holding to Solana (SOL), providing investors with direct economic exposure to SOL while participating in the growth of the Solana ecosystem [3] - The company operates its own validator infrastructure, generating staking rewards and fees from delegated stake, and is engaged in decentralized finance (DeFi) opportunities [3] - DeFi Development Corp. serves over one million web users annually, including property owners, developers, and various lenders, applying for billions of dollars in debt financing each year [5] Recent Developments - The company announced a live X Spaces event scheduled for August 27, 2025, at 4:30 PM ET, featuring insights into a recently announced $125 million equity raise [1][7] - The event will cover the structure of the equity raise, the rationale behind it, intended use of proceeds, and the company's role in expanding Solana adoption [7] Business Model - The company's data and software offerings are primarily provided on a subscription basis as software as a service (SaaS), catering to the commercial real estate industry [4][5] - DeFi Development Corp. connects stakeholders in the commercial real estate ecosystem, providing data and software subscriptions along with value-added services [4]

Core Points - Cognition Therapeutics, Inc. has regained compliance with Nasdaq's minimum share price requirement under Rule 5550(a)(2) [1][2] - The company achieved a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, with the requirement fulfilled on August 25, 2025 [2] - Cognition Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics for neurodegenerative disorders [3] Company Overview - Cognition Therapeutics is currently developing zervimesine (CT1812), targeting dementia with Lewy bodies, mild-to-moderate Alzheimer's disease, and geographic atrophy secondary to dry AMD [3] - The Phase 2 START study in early Alzheimer's disease is ongoing, supported by $81 million in grants from the National Institute of Aging [3] - The mechanism of zervimesine involves interaction with the sigma-2 receptor, which is distinct from other treatment approaches for degenerative diseases [3]

Company to host conference call at 8 a.m. ET, August 27, 2025NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will host an investor call and live webcast at 8 a.m. ET, August 27, 2025 to review topline data from the SERENITY At-Home Pivotal Phase 3 trial evaluating the safety of BXCL501, the Company’s proprietary, sublingual ...

Core Insights - VCI Global Limited has secured a US$22 million contract with Codetext for sovereign AI infrastructure, marking a significant milestone in the cybersecurity and AI sector [1][2][5] Company Overview - V Gallant Limited, a subsidiary of VCI Global, specializes in AI infrastructure and cybersecurity solutions, providing advanced technologies for secure and innovative operations [8][9] - The company aims to empower governments and enterprises in Southeast Asia to scale securely and independently, focusing on digital sovereignty and national security [10] Contract Details - The contract involves the delivery of a full-stack sovereign AI system, incorporating military-grade encryption and NVIDIA-powered compute systems, ensuring high-performance AI operations [2][6] - Key components of the system include QuantVault for encrypted data storage, QTrustCard for hardware-level security, SecureGPU™ for processing large AI workloads, and a Local AI Stack Integration for regulatory-compliant control [8] Market Context - The demand for sovereign AI infrastructure is increasing due to regulatory requirements and rising cybersecurity risks, with the AI infrastructure market projected to reach approximately US$197.6 billion by 2030, growing at a 17.7% CAGR [5] - Southeast Asia's data center investments are expected to grow to around US$17.7 billion by 2029, positioning VCI Global as a first mover in this expanding market [5] Strategic Positioning - The partnership with Codetext enhances VCI Global's ability to deliver trusted, next-generation solutions while ensuring regulatory compliance and operational independence for clients [4][6] - The infrastructure ensures data sovereignty by keeping information within jurisdictional boundaries, meeting stringent security and compliance requirements [6]

Company Overview - Liquidity Services (NASDAQ:LQDT) is a leading global commerce company that operates the world's largest B2B e-commerce marketplace platform for surplus assets, with over $15 billion in completed transactions [2] - The company has more than five million qualified buyers and 15,000 corporate and government sellers worldwide [2] - Liquidity Services supports sustainability efforts by helping clients extend the life of assets, prevent unnecessary waste and carbon emissions, and reduce landfill contributions [2] Event Participation - Bill Angrick, Co-Founder, Chairman, and CEO of Liquidity Services, will present at the Midwest IDEAS conference on August 27, 2025, in Chicago, IL [1] - The conference will feature leaders and innovators engaging in one-on-one meetings to discuss emerging trends influencing the future [1]

Core Viewpoint - Troilus Gold Corp. has signed a Memorandum of Agreement with Aurubis AG for the long-term offtake of copper-gold concentrate from the Troilus Project in Québec, Canada, marking a significant step in project financing and development [1][3][4] Group 1: Agreement Details - The MoA formalizes the offtake terms previously indicated on June 18, 2025, and establishes a framework for long-term concentrate supply [1][3] - The agreement was signed during Canada's Critical Minerals Mission to Germany, highlighting the international significance of the project [2][4] - The MoA covers a substantial portion of Troilus' concentrate to be delivered to Aurubis, aligning with a broader debt financing package of up to US$700 million announced on March 13, 2025 [3][4] Group 2: Strategic Importance - The partnership is seen as a step forward in enhancing Canada-Europe cooperation on critical minerals, reinforcing Canada's position as a reliable supplier of responsibly sourced copper and gold [4][6] - The agreement underscores the importance of Canadian critical mineral projects in strengthening global supply chains and positions Troilus as a future North American supplier to European markets [6] Group 3: Support and Advisory - Ocean Partners USA Inc. is acting as Troilus' independent third-party advisor, providing market insight and guidance for the concentrate offtake strategy [7] - Auramet International Inc. is assisting with structuring the debt package and engaging with potential lenders and strategic partners [8]

Core Insights - Tevogen Bio Holdings Inc. has been recognized by Yale University for its commitment to health equity and the leadership of its Founder and CEO, Dr. Ryan Saadi [2] - The company operates with a lean, capital-efficient business model, fully owning its core intellectual property to minimize costs and complexity in developing CD8+ T cell therapies [3] - Dr. Saadi emphasized that affordability and accessibility are foundational to Tevogen's operations, achieving significant milestones with lower capital expenditure compared to industry norms [4] Business Model and Strategy - Tevogen's business model is designed to withstand market pressures through a capital-efficient structure, focusing on off-the-shelf, genetically unmodified therapies [3] - The company has avoided the typical billion-dollar burn rate seen in the industry, maintaining a lean cash run rate while preserving equity [4] - Tevogen aims to deliver innovative therapies that not only improve patient outcomes but also achieve commercial success at a lower cost [4] Recognition and Impact - The recognition from Yale highlights the impact of Tevogen's mission on making healthcare more affordable and accessible [2] - Dr. Saadi's vision is acknowledged as a significant contribution to the healthcare landscape, reinforcing the company's commitment to health equity [2][4]

IS Kredit SPV 21 hs. er sérhæfður sjóður í rekstri Íslandssjóða hf. Sjóðurinn gaf út skuldabréf sem tekin voru til viðskipta hjá Nasdaq Iceland hf. í september 2022 sem flokkast undir félagslegan fjármögnunarramma. Meðfylgjandi er árshlutareikningur sjóðsins fyrir fyrstu sex mánuði ársins 2025. Rekstrarniðurstaða sjóðsins fyrstu sex mánuði ársins 2025 var 0 kr. og eignir sjóðsins námu samtals um 14,6 milljörðum kr. í lok tímabilsins. Nánari upplýsingar veitir: Gísli Elvar Halldórsson, gislielvar@islandssjo ...

IS Fyrirtækjalánasjóður hs. er sérhæfður sjóður í rekstri Íslandssjóða hf. Sjóðurinn gaf út skuldabréf sem tekin voru til viðskipta hjá Nasdaq Iceland hf. í nóvember 2024. Meðfylgjandi er árshlutareikningur sjóðsins fyrir fyrstu sex mánuði ársins 2025. Rekstrarniðurstaða sjóðsins fyrstu sex mánuði ársins 2025 var 211 milljónir kr. og eignir sjóðsins námu samtals um 8,5 milljörðum kr. í lok tímabilsins. Nánari upplýsingar veitir: Gísli Elvar Halldórsson, gislielvar@islandssjodir.is Attachment Árshlutar ...

Dividend payable on September 26, 2025Quakertown, PA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of QNB Corp. (OTCQX: QNBC), parent company of QNB Bank, at a regular meeting on August 26, declared a quarterly cash dividend of $0.38 per share. The cash dividend is payable on September 26, 2025, to shareholders of record September 12, 2025. QNB Corp. offers commercial and retail banking services through the twelve banking offices of its subsidiary, QNB Bank. QNB Corp.’s stock is traded in the ov ...